| CASE REPORT |
|
| Year : 2023 | Volume
: 24
| Issue : 4 | Page : 210-211 |
|
|
A case of ticagrelor-induced seizure
Fatih Selvi, Cihan Bedel, Bora Baltacioglu, Günay Yıldız
Department of Emergency Medicine, Health Science University, Antalya Training and Research Hospital, Antalya, Turkey
Correspondence Address:
Dr. Cihan Bedel
Department of Emergency Medicine, Health Science University Antalya Training and Research Hospital, Kazim Karabekir Street, Muratpasa, Antalya 07100
Turkey
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/heartviews.heartviews_20_23
|
|
|
Ticagrelor is available as an oral antiplatelet agent that can bind reversibly to the adenosine diphosphate receptor P2Y12 on platelets without first having to be activated. Main side effects such as dizziness, bleeding gums, nausea in common, difficulty in speaking, fever, and change in mental status are rare. Herein, we report a patient who had seizures after the usage of ticagrelor.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
